Companies / Connecticut / Allyx Therapeutics

· rebuilt nightly from public records

Signal Sheet

Selling to Allyx Therapeutics? Who to reach and why now

Allyx Therapeutics is a private biotechnology company in New Haven, Connecticut. It raised $26.4M in May 2026 and its filings name 8 officers. Everything below links to the record it came from.

Private company · Biotechnology · Connecticut

The easy button for new customers

Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.

Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.

SourceNew accounts that match what you offer, added as the signals land. The list never runs dry.
Reach outA first email written from why the account is hot, then a drip sequence that follows up until they reply. Sent from your own mailbox, with every open and reply tracked.
PursueAn AI-written plan built from your value proposition and the customer's compelling event: who to call, what to lead with, and the next step to win it. In early access.
Start your free trial →Tell it what you sell and where. Your list stays yours.

Who to reach

The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names

RoleContactSourceWhy they matter now
Executive OfficerStephen BlochSEC filing, May 2026Named officer in the filing; part of the buying group
Executive OfficerTimothy SiegertSEC filing, May 2026Named officer in the filing; part of the buying group
Executive OfficerJennifer GablerSEC filing, Feb 2026Named officer in the filing; part of the buying group
Chief Technology OfficerStephen StrittmatterSEC filing, May 2026Technology and tooling decisions
Chief Technology OfficerPaul FonteyneSEC filing, May 2026Technology and tooling decisions
Chief Technology OfficerGregory P HoSEC filing, May 2026Technology and tooling decisions
Chief Technology OfficerRobert A BettigoleSEC filing, May 2026Technology and tooling decisions
Chief Technology OfficerKevin L. RakinSEC filing, May 2026Technology and tooling decisions
For sellersWhy Allyx Therapeutics is worth a call this quarterBuy Window: watching
$26.4M

Raised

Equity raise reported to the SEC, May 2026. Money arrives before the spending plan does.

Capital
$29.8M3 months

Back-to-back raises

2 equity raises in 3 months. Repeat funding is a company buying for growth, not maintenance.

Pattern
8officers

Named in filings

Each with a title and the filing that names them, so the first call goes to the right desk.

People
Track Allyx Therapeutics with a free trial →Get the next signal the day it is filed or posted.
Email me the next Allyx Therapeutics signalOne email when it files, raises, hires or posts a role. Watch up to 3 companies free, no password.

Why now

The most recent events first, refreshed every night. Each links to the record it came from.

WhenWhat happenedKindSource
May 4, 2026Raised $27.9M in equity from 33 investorsCapitalSEC filing
May 4, 2026Raised $26.4M in equity from 32 investorsCapitalSEC filing
Feb 23, 2026Raised $3.3M in equity from 12 investorsCapitalSEC filing

Email format

Allyx Therapeutics uses [email protected]. For someone named Jane Doe that is [email protected]. Lakewave confirmed this pattern. A company pattern is the common shape, not a guarantee for any one person. Many companies run more than one format at once: founders, early hires, acquired teams and regional offices often differ. So Lakewave does not apply one pattern across a whole company. It verifies the address for each person on its own, and a free trial gives you the email that reaches each person above.
Get verified addresses, free →

Reach Allyx Therapeutics with emails that land

Lakewave finds the right people at Allyx Therapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.

Try it on Allyx Therapeutics with a free trial →

About Allyx Therapeutics

HeadquartersNew Haven, Connecticut, per the filing address
Industry groupBiotechnology
OwnershipPrivate company
Raise history$3.3M (Feb 2026) · $26.4M (May 2026)
Lakewave Rising9 · 1 kinds of evidence · rank in Connecticut after sign-up

Similar companies

Private-sector companies in the same industry group and state, ranked by Rising score.

Cloverleaf Bio · 15Oncosynergy · 6Quarry Heme · 5See all 3 with a free trial →

Questions people ask

Did Allyx Therapeutics raise funding in 2026?

Yes. Allyx Therapeutics reported a $26.4M equity raise to the SEC on May 4, 2026 with 33 investors.

Who runs Allyx Therapeutics?

The company's SEC filing, May 2026 names Stephen Bloch (Executive Officer) among its officers.

Where is Allyx Therapeutics headquartered?

New Haven, Connecticut, per the address on its SEC filing.

What is Allyx Therapeutics's email format?

Allyx Therapeutics uses [email protected]. For someone named Jane Doe that is [email protected]. Lakewave confirmed this pattern.

Does everyone at Allyx Therapeutics use the same email format?

Not always. Many companies run more than one format at once: founders, early hires, acquired teams and regional offices often differ. That is why Lakewave does not apply one pattern across a whole company. It verifies the address for each person on its own, so you are not relying on a guessed pattern.

Know who is buying before the first callStart your free trial →

Know who is buying before the first call

Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.

Start your free trial

Compiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.